Valuation (31%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -42.39 | 15.12 |
| PEG Ratio (TTM) | 0.47 | -0.22 |
| P/S Ratio (TTM) | 1.71 | 3.93 |
| P/B Ratio (TTM) | 1.24 | 2.92 |
| P/FCF Ratio (TTM) | -3.24 | 15.37 |
| Price to 5YR AVG Earnings Ratio | N/A | 37.87 |
| Price to 5YR AVG FCF Ratio | N/A | 22.26 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -1.54% | 10.13% |
| ROE (TTM) | -3.07% | 19.03% |
| Net Profit Margin (TTM) | -3.77% | -40.31% |
| ROIC 5YR AVG | N/A | 23.84% |
Growth (13%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -33.91% | N/A | N/A |
| Revenue | 11.75% | N/A | N/A |
| Net Income | -33.23% | N/A | N/A |
| Cash Flow | 2.48% | N/A | N/A |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.24 | 1.72 |
| Quick Ratio (TTM) | 1.16 | 1.60 |
| D/E Ratio (TTM) | 0.63 | 16.17 |
| Interest Coverage (TTM) | 3.71 | 18.18 |
| Piotroski F-Score | 6 | 6 |
| Altman Z-Score | 1.80 | 2.90 |
| LTL to 5YR AVG FCF | N/A | 15.40 |
| Shares Outstanding Growth 5YR AVG | N/A | 17.62% |